Cubist Systematic Strategies’s Cardiff Oncology CRDF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$183K Buy
+88,903
New +$246K ﹤0.01% 2676
2024
Q3
Sell
-68,730
Closed -$153K 3054
2024
Q2
$153K Buy
68,730
+36,441
+113% +$137K ﹤0.01% 2563
2024
Q1
$172K Buy
+32,289
New +$85.8K ﹤0.01% 3140
2022
Q2
Sell
-69,090
Closed -$171K 4384
2022
Q1
$171K Buy
69,090
+59,639
+631% +$211K ﹤0.01% 3093
2021
Q4
$57K Sell
9,451
-16,233
-63% -$96.8K ﹤0.01% 3292
2021
Q3
$171K Sell
25,684
-21,660
-46% -$136K ﹤0.01% 2629
2021
Q2
$315K Sell
47,344
-44,679
-49% -$379K ﹤0.01% 2294
2021
Q1
$852K Buy
92,023
+25,334
+38% +$308K 0.01% 1636
2020
Q4
$1.2M Buy
+66,689
New +$1.17M 0.02% 1260

Other funds holding CRDF

Cubist Systematic Strategies's CRDF Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in Cardiff Oncology (CRDF) in Q3 2025: 88,903 shares worth $183K. The stake represents ﹤0.01% of the portfolio and ranks #2676 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in CRDF as recently as Q2 2024.

Cubist Systematic Strategies first reported a position in CRDF in Q4 2020 and has held it in 9 quarters since. The position peaked at $1.2M in Q4 2020. 112 funds tracked by Wall St. Rank hold CRDF as of Q3 2025.

  • Cubist Systematic Strategies held 88,903 shares of Cardiff Oncology worth $183K as of Q3 2025.
  • Cardiff Oncology was a new Cubist Systematic Strategies position in Q3 2025.
  • Cardiff Oncology made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2676 holding.
  • Cubist Systematic Strategies first reported a position in Cardiff Oncology in Q4 2020 and has held it in 9 quarters since.
  • Cubist Systematic Strategies's Cardiff Oncology position peaked at $1.2M in Q4 2020.
  • 112 funds tracked by Wall St. Rank held Cardiff Oncology as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.